Geode Capital Management
WST icon

Geode Capital Management’s West Pharmaceutical WST Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$399M Sell
1,833,004
-20,689
-1% -$4.51M 0.03% 462
2025
Q1
$414M Buy
1,853,693
+74,753
+4% +$16.7M 0.03% 436
2024
Q4
$581M Buy
1,778,940
+38,757
+2% +$12.7M 0.05% 349
2024
Q3
$521M Buy
1,740,183
+12,850
+0.7% +$3.84M 0.04% 366
2024
Q2
$567M Buy
1,727,333
+9,937
+0.6% +$3.26M 0.05% 324
2024
Q1
$678M Buy
1,717,396
+49,349
+3% +$19.5M 0.06% 289
2023
Q4
$586M Buy
1,668,047
+49,578
+3% +$17.4M 0.06% 295
2023
Q3
$606M Buy
1,618,469
+27,971
+2% +$10.5M 0.07% 261
2023
Q2
$607M Buy
1,590,498
+48,047
+3% +$18.3M 0.07% 266
2023
Q1
$533M Buy
1,542,451
+35,627
+2% +$12.3M 0.07% 285
2022
Q4
$354M Buy
1,506,824
+36,935
+3% +$8.68M 0.05% 364
2022
Q3
$361M Buy
1,469,889
+28,366
+2% +$6.97M 0.05% 338
2022
Q2
$435M Buy
1,441,523
+12,437
+0.9% +$3.75M 0.06% 295
2022
Q1
$586M Buy
1,429,086
+47,070
+3% +$19.3M 0.07% 266
2021
Q4
$647M Buy
1,382,016
+40,280
+3% +$18.8M 0.08% 248
2021
Q3
$568M Buy
1,341,736
+42,648
+3% +$18.1M 0.08% 251
2021
Q2
$465M Buy
1,299,088
+540
+0% +$193K 0.06% 302
2021
Q1
$365M Buy
1,298,548
+41,626
+3% +$11.7M 0.06% 338
2020
Q4
$355M Buy
1,256,922
+38,512
+3% +$10.9M 0.06% 312
2020
Q3
$334M Buy
1,218,410
+10,881
+0.9% +$2.99M 0.07% 277
2020
Q2
$274M Buy
1,207,529
+269,961
+29% +$61.2M 0.06% 303
2020
Q1
$143M Buy
937,568
+64,051
+7% +$9.74M 0.04% 412
2019
Q4
$131M Buy
873,517
+43,022
+5% +$6.46M 0.03% 514
2019
Q3
$118M Buy
830,495
+19,128
+2% +$2.71M 0.03% 518
2019
Q2
$102M Sell
811,367
-2,074
-0.3% -$260K 0.02% 557
2019
Q1
$89.6M Buy
813,441
+70,288
+9% +$7.75M 0.02% 580
2018
Q4
$72.9M Buy
743,153
+73,058
+11% +$7.16M 0.02% 578
2018
Q3
$82.7M Buy
670,095
+19,909
+3% +$2.46M 0.02% 581
2018
Q2
$64.6M Buy
650,186
+38,689
+6% +$3.84M 0.02% 652
2018
Q1
$54M Buy
611,497
+20,359
+3% +$1.8M 0.02% 698
2017
Q4
$58.3M Buy
591,138
+12,420
+2% +$1.23M 0.02% 646
2017
Q3
$55.7M Buy
578,718
+3,421
+0.6% +$329K 0.02% 629
2017
Q2
$54.4M Buy
575,297
+26,634
+5% +$2.52M 0.02% 623
2017
Q1
$44.8M Buy
548,663
+32,548
+6% +$2.66M 0.02% 688
2016
Q4
$43.8M Buy
516,115
+18,315
+4% +$1.55M 0.02% 641
2016
Q3
$37.1M Buy
497,800
+11,008
+2% +$820K 0.02% 673
2016
Q2
$36.9M Buy
486,792
+6,951
+1% +$527K 0.02% 639
2016
Q1
$33.3K Buy
479,841
+23,029
+5% +$1.6K 0.02% 673
2015
Q4
$27.5M Buy
456,812
+20,033
+5% +$1.21M 0.02% 737
2015
Q3
$23.6M Buy
436,779
+3,988
+0.9% +$216K 0.01% 792
2015
Q2
$25.1M Buy
432,791
+24,896
+6% +$1.45M 0.01% 805
2015
Q1
$24.6M Buy
407,895
+5,202
+1% +$313K 0.01% 805
2014
Q4
$21.4M Buy
402,693
+12,363
+3% +$658K 0.01% 829
2014
Q3
$17.5M Sell
390,330
-6,972
-2% -$312K 0.01% 898
2014
Q2
$16.8M Sell
397,302
-45,967
-10% -$1.94M 0.01% 948
2014
Q1
$19.5M Buy
443,269
+2,373
+0.5% +$105K 0.01% 834
2013
Q4
$21.6M Buy
440,896
+91,882
+26% +$4.51M 0.02% 745
2013
Q3
$14.4M Buy
349,014
+187,773
+116% +$7.73M 0.01% 856
2013
Q2
$11.3M Buy
+161,241
New +$11.3M 0.01% 886